|
Characteristics of CLO patients |
||||||||
| Ref |
Year |
Country |
N |
M:F |
Mean Age (Diagnosis) |
Type of study |
||
| M |
(Total) |
F |
||||||
|
|
||||||||
| 39 |
1992 |
UK |
102 |
0.9 |
60.3 |
57.7 |
Consecutive surveillance patients |
|
| 40 |
1996 |
Netherlands |
166 |
1.4 |
62.0 |
Cohort |
||
| 41 |
1997 |
UK |
232 |
2.0 |
63.0 |
73.0 |
Prospective screening |
|
| 18 |
1997 |
Australia |
158 |
0.5 |
50.8 |
Consecutive SSB patients |
||
| 42 |
1998 |
UK |
268 |
1.7 |
60.2 |
70.0 |
Cohort |
|
| 43 |
2000 |
UK |
5717 |
1,7 |
61.4 |
67.5 |
Cohort |
|
| 44 |
2000 |
UK |
409 |
1.1 |
63.0 |
Cohort |
||
| 45 |
2002 |
Chile |
408 |
0.9 |
53.0 |
Consecutive endoscopy patients |
||
| 46 |
2003 |
UK |
232 |
1.7 |
- |
Consecutive endoscopy patients |
||
Caygill et al. World Journal of Surgical Oncology 2004 2:12 doi:10.1186/1477-7819-2-12 |
||||||||